Antithrombotic therapy in cardiac stent patients

被引：6

作者：

Cannan C.R. ^{[1
]}

机构：

[1] Division of Cardiovascular Diseases, Oregon Health Sciences University, Portland, OR 97201

来源：

Current Cardiology Reports | 2001年 / 3卷 / 1期

关键词：

Clopidogrel; Stent Placement; Abciximab; Stent Thrombosis; Ticlopidine;

D O I：

10.1007/s11886-001-0014-0

中图分类号：

学科分类号：

摘要：

The use of coronary stents has made a significant impact on immediate angiographic results of coronary angioplasty as well as on the more important incidence of restenosis and the need for repeat procedures. This could not have been accomplished without adjuvant antithrombotic therapy directed predominantly at platelet function. Antiplatelet agents have significantly reduced the complications and improved the long-term outcome following coronary stent placement. This paper reviews the evolution of adjuvant antithrombotic therapy following stent placement, the agents currently used and future directions being investigated. Copyright © 2001 by Current Science Inc.

引用

页码：78 / 84

页数：6

共 32 条

[1]

Topol E.J., Mark D.B., Lincoff A.M., Et al., Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: Results from a multicentre randomised trial. EPISTENT Investigators, Lancet, 354, pp. 2019-2024, (1999)

[2]

Serruys P.W., Dejacgere P., Kiemeneij F., Et al., For the Benestent Study Group: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease, N Engl J Med, 331, pp. 489-495, (1994)

[3]

Fischman D.L., Leon M.B., Baim D.S., Et al., For the Stent Restenosis Study Investigators: A randomized comparison of coronarystent placement and balloon angioplasty in the treatment of coronary artery disease, N Engl J Med, 331, pp. 496-501, (1994)

[4]

Sigwart U., Puel J., Mirkovitch V., Et al., Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty, N Engl J Med, 316, pp. 701-706, (1987)

[5]

Hasdai D., Garratt K.N., Holmes Jr. D.R., Et al., Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis, J Am Coll Cardiol, 28, pp. 361-367, (1996)

[6]

Jeong M.H., Owen W.G., Staab M.E., Et al., Porcine model of stent thrombosis: Platelets are the primary component of acute stent closure, Cathet Cardiovasc Diagn, 38, pp. 38-43, (1996)

[7]

Colombo A., Hall P., Nakamura S., Et al., Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance, Circulation, 91, pp. 1676-1688, (1995)

[8]

Schomig A., Neumann F.J., Kastrati A., Et al., A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stent, N Engl J Med, 334, pp. 1084-1089, (1996)

[9]

Leon M.B., Baim D.S., Popma J.J., Et al., A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators, N Engl J Med, 339, pp. 1665-1671, (1998)

[10]

Bertrand M.E., Legrand V., Boland J., Et al., Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study, Circulation, 98, pp. 1597-1603, (1998)

← 1 2 3 4 →